Exane Derivatives’s Ryder R Stock Holding History

Exane Derivatives’s Portfolio R Stock Details R Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-110	Closed	-$9.1K	–	945
2021 Q3	$9.1K	Hold	110	–	–	﹤0.01%	712
2021 Q2	$8.13K	Buy	+110	New	+$8.7K	﹤0.01%	752

Other funds holding R

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HVCM

HG Vora Capital Management New York $197M AUM 17.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Exane Derivatives's R Position: Q4 2021 in Review

Exane Derivatives sold out of Ryder (R) in Q4 2021, closing a stake of 110 shares — an estimated $9.1K sold.

Exane Derivatives first reported a position in R in Q2 2021 and held it in 2 quarters. The position peaked at $9.1K in Q3 2021. 355 funds tracked by Wall St. Rank hold R as of Q4 2021.

Exane Derivatives reported no remaining Ryder position as of Q4 2021 after selling out during the quarter.
Exane Derivatives sold 110 Ryder shares in Q4 2021, an estimated $9.1K.
Exane Derivatives first reported a position in Ryder in Q2 2021 and held it in 2 quarters.
Exane Derivatives's Ryder position peaked at $9.1K in Q3 2021.
355 funds tracked by Wall St. Rank held Ryder as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.